BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18030365)

  • 1. Hypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumors.
    Chilukamarri L; Hancock AL; Malik S; Zabkiewicz J; Baker JA; Greenhough A; Dallosso AR; Huang TH; Royer-Pokora B; Brown KW; Malik K
    Neoplasia; 2007 Nov; 9(11):970-8. PubMed ID: 18030365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
    Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
    Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.
    Chung WY; Yuan L; Feng L; Hensle T; Tycko B
    Hum Mol Genet; 1996 Aug; 5(8):1101-8. PubMed ID: 8842727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective methylation of CpGs at regulatory binding sites controls NNAT expression in Wilms tumors.
    Hubertus J; Zitzmann F; Trippel F; Müller-Höcker J; Stehr M; von Schweinitz D; Kappler R
    PLoS One; 2013; 8(6):e67605. PubMed ID: 23825673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
    Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B
    Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomethylation and hypermethylation of DNA in Wilms tumors.
    Ehrlich M; Jiang G; Fiala E; Dome JS; Yu MC; Long TI; Youn B; Sohn OS; Widschwendter M; Tomlinson GE; Chintagumpala M; Champagne M; Parham D; Liang G; Malik K; Laird PW
    Oncogene; 2002 Sep; 21(43):6694-702. PubMed ID: 12242669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer.
    Ren C; Li L; Yang G; Timme TL; Goltsov A; Ren C; Ji X; Addai J; Luo H; Ittmann MM; Thompson TC
    Cancer Res; 2004 Feb; 64(3):969-76. PubMed ID: 14871827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis.
    Xiao YH; Li XH; Tan T; Liang T; Yi H; Li MY; Zeng GQ; Wan XX; Qu JQ; He QY; Li JH; Chen Y; Xiao ZQ
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1831-40. PubMed ID: 21922325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of imprinted genes in Wilms tumors.
    Hubertus J; Lacher M; Rottenkolber M; Müller-Höcker J; Berger M; Stehr M; von Schweinitz D; Kappler R
    Oncol Rep; 2011 Mar; 25(3):817-23. PubMed ID: 21174059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.
    Haruta M; Arai Y; Watanabe N; Fujiwara Y; Honda S; Ohshima J; Kasai F; Nakadate H; Horie H; Okita H; Hata J; Fukuzawa M; Kaneko Y
    Cancer Sci; 2012 Jun; 103(6):1129-35. PubMed ID: 22409817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor.
    Malik K; Salpekar A; Hancock A; Moorwood K; Jackson S; Charles A; Brown KW
    Cancer Res; 2000 May; 60(9):2356-60. PubMed ID: 10811108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic lesions at the H19 locus in Wilms' tumour patients.
    Moulton T; Crenshaw T; Hao Y; Moosikasuwan J; Lin N; Dembitzer F; Hensle T; Weiss L; McMorrow L; Loew T; Kraus W; Gerald W; Tycko B
    Nat Genet; 1994 Jul; 7(3):440-7. PubMed ID: 7920666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teratoma-associated and so-called pure Wilms tumour of the ovary represent two separate tumour types with distinct molecular features.
    Kommoss FKF; Chong AS; Apellaniz-Ruiz M; Turashvili G; Park KJ; Hanley K; Valera ET; von Deimling A; Vujanic G; McCluggage WG; Foulkes WD
    Histopathology; 2024 Mar; 84(4):683-696. PubMed ID: 38084641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.
    Satoh Y; Nakagawachi T; Nakadate H; Kaneko Y; Masaki Z; Mukai T; Soejima H
    J Biochem; 2003 Mar; 133(3):303-8. PubMed ID: 12761165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent hypermethylation of a CTCF binding site influences Wilms tumor 1 expression in Wilms tumors.
    Zitzmann F; Mayr D; Berger M; Stehr M; von Schweinitz D; Kappler R; Hubertus J
    Oncol Rep; 2014 Apr; 31(4):1871-6. PubMed ID: 24534946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset.
    Maschietto M; Trapé AP; Piccoli FS; Ricca TI; Dias AA; Coudry RA; Galante PA; Torres C; Fahhan L; Lourenço S; Grundy PE; de Camargo B; de Souza S; Neves EJ; Soares FA; Brentani H; Carraro DM
    Cell Death Dis; 2011 Nov; 2(11):e224. PubMed ID: 22048167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of hepatocyte growth factor and its receptor met in Wilms' tumors and nephrogenic rests reflects their roles in kidney development.
    Vuononvirta R; Sebire NJ; Messahel B; Perusinghe N; Reis-Filho JS; Pritchard-Jones K; Vujanic GM; Jones C
    Clin Cancer Res; 2009 Apr; 15(8):2723-30. PubMed ID: 19318497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic imprinting and Wilms' tumor.
    Moulton T; Chung WY; Yuan L; Hensle T; Waber P; Nisen P; Tycko B
    Med Pediatr Oncol; 1996 Nov; 27(5):476-83. PubMed ID: 8827077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.
    Dallosso AR; Hancock AL; Szemes M; Moorwood K; Chilukamarri L; Tsai HH; Sarkar A; Barasch J; Vuononvirta R; Jones C; Pritchard-Jones K; Royer-Pokora B; Lee SB; Owen C; Malik S; Feng Y; Frank M; Ward A; Brown KW; Malik K
    PLoS Genet; 2009 Nov; 5(11):e1000745. PubMed ID: 19956686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.